Benzinga
Benzinga
Benzinga
mercoledì, settembre 16

Pomdoctor Ltd

POMNASDAQ
Trade with Public
Trade with Public
$0.8007
0.0466.1%
In chiusura: Sep 16, 5:00 PM EST
$0.9000
0.099312.4%
Post-mercato: 4:39 PM EST
PanoramicaNotiziePrevisioni utiliEventiDati finanziariSentimentConfrontaRapporto azionario

Pomdoctor Financials

Pomdoctor (POM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Pomdoctor FY EPS $(3.14), Sales $57.187M

Pomdoctor (NASDAQ:POM) reported quarterly losses of $(3.14) per share. The company reported $57.187 million in sales this quarter.
Benzinga Newsdesk

Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results

Avi Kapoor

US Stocks Mixed Ahead Of Fed Decision; Dow Surges 100 Points

Avi Kapoor

PRO
Pomdoctor H1 EPS $(1.60), Sales $24.400M

Pomdoctor (NASDAQ:POM) reported quarterly losses of $(1.60) per share. The company reported $24.400 million in sales this quarter.
Benzinga Newsdesk

PolyMet Q2 EPS ($0.01) vs ($0.01) est, No Revenue

Benzinga

Mid-Afternoon Market Update: American Public Education Rises Following Q4 Results; PTC Therapeutics Shares Fall

Benzinga

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved